Non Small Cell Lung Cancer Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
P
Recruiting
  • Oncology
  • +9 more
  • E-602
  • Pembrolizumab
  • Grand Rapids, Michigan
  • +2 more
2022-04-07
Apr 7, 2022
T
Not yet recruiting
  • Lung Cancer
  • +4 more
  • Anlotinib and Penpulimab
  • Xinxiang, Henan, China
    Department of Oncology, The First Affiliated Hospital of Xinxian
2022-04-01
Apr 1, 2022
I
Recruiting
  • Ovarian Cancer
  • +10 more
  • West Hollywood, California
  • +26 more
2022-04-06
Apr 6, 2022
N
Recruiting
  • Lung Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
A
Recruiting
  • Advanced Solid Cancer
  • +4 more
  • Beijing, Beijing, China
  • +9 more
2022-04-07
Apr 7, 2022
F
Recruiting
  • Non Small Cell Lung Cancer
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
2022-04-06
Apr 6, 2022
M
Recruiting
  • Mesothelioma
  • +5 more
  • Nashville, Tennessee
  • +2 more
2022-04-06
Apr 6, 2022
H
Recruiting
  • Gastric Cancer
  • +8 more
  • Los Angeles, California
  • +2 more
2022-04-05
Apr 5, 2022
W
Not yet recruiting
  • Non Small Cell Lung Cancer
  • Non-small Cell Lung Cancer
    • Atlanta, Georgia
    • +6 more
    2022-03-29
    Mar 29, 2022
    J
    Recruiting
    • Non Small Cell Lung Cancer
    • Goyang-si, Gyeonggi-do, Korea, Republic of
      National Cancer Center
    2022-04-04
    Apr 4, 2022
    L
    Available
    • Non Small Cell Lung Cancer
    • +6 more
    • Goodyear, Arizona
    • +68 more
    2022-04-05
    Apr 5, 2022
    N
    Active, not recruiting
    • Non Small Cell Lung Cancer
      • Goyang, Gyeonggi-do, Korea, Republic of
        National Cancer Center (NCC) Korea
      2022-04-05
      Apr 5, 2022
      H
      Recruiting
      • Non Small Cell Lung Cancer
      • +6 more
      • Encinitas, California
      • +5 more
      2022-04-04
      Apr 4, 2022
      P
      Recruiting
      • Non Small Cell Lung Cancer
      • Cisplatin / Carboplatin,Gemcitabine,Cindilimab
      • Quzhou, Zhejiang, China
        Quzhou people's Hospital
      2022-04-02
      Apr 2, 2022
      N
      Recruiting
      • Non Small Cell Lung Cancer
      • +2 more
        • Moscow, Russian Federation
          Federal State Budgetary Institution National Medical Research Ce
        2022-03-29
        Mar 29, 2022
        I
        Withdrawn
        • Non Small Cell Lung Cancer
        • El Segundo, California
          Chan Soon-Shiong Institute for Medicine
        2022-03-28
        Mar 28, 2022
        N
        Not yet recruiting
        • Pancreatic Cancer
        • +15 more
        • (no location specified)
        2022-03-27
        Mar 27, 2022
        H
        Not yet recruiting
        • Non Small Cell Lung Cancer
        • IBI-322 Plus Bevacizumab and Platinum
        • Changsha, Hunan, China
          Hunan Cancer hospital
        2022-03-24
        Mar 24, 2022
        U
        Completed
        • Non Small Cell Lung Cancer
        • High protein/high dairy
        • Edmonton, Alberta, Canada
          Cross Cancer Institute
        2022-04-03
        Apr 3, 2022
        P
        Recruiting
        • Non Small Cell Lung Cancer
        • +3 more
        • NEO-201 in combination with pembrolizumab
        • Bethesda, Maryland
          National Cancer Institute
        2022-04-01
        Apr 1, 2022
        I
        Recruiting
        • Non Small Cell Lung Cancer
        • N-803 + Pembrolizumab
        • +5 more
        • Anchorage, Alaska
        • +32 more
        2022-04-01
        Apr 1, 2022
        P
        Recruiting
        • Breast Cancer
        • +8 more
        • Denver, Colorado
        • +1 more
        2022-04-01
        Apr 1, 2022
        A
        Not yet recruiting
        • Non Small Cell Lung Cancer
        • Supervised physical activity
        • Unsupervised physical activity
        • (no location specified)
        2022-03-23
        Mar 23, 2022
        A
        Active, not recruiting
        • Non Small Cell Lung Cancer Metastatic
        • +3 more
        • Tucson, Arizona
        • +36 more
        2022-03-31
        Mar 31, 2022
        A
        Recruiting
        • Non Small Cell Lung Cancer
        • +3 more
        • Birmingham, Alabama
        • +79 more
        2022-03-31
        Mar 31, 2022